Cart
0

World Clinical Nutrition Market - Opportunities and Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_18861
Pages: NA
Dec 2018 | 1442 Views
 
Author's : NA
Tables: NA
Charts: NA
 

Clinical nutrition products are type of pharmaceutical products, which help to keep patient healthy. They aid to improve metabolic system of the body by providing adequate supplements such as minerals, vitamins and others. Rising instances of chronic and lifestyle diseases and increasing population that receives malnutrition treatment are the major factors responsible for driving the growth of the market. Furthermore, rise in global population, disposable income, premature births, investment from major players & governments, and awareness among people are expected to drive the growth of the market. However, stringent regulatory scenario and tolerability issues are expected to slow down the growth of the market.

The clinical nutrition market is segmented by type and geography. Based on type, it is segmented into infant, enteral, and parenteral nutrition. The infant nutrition sub-segment consists of milk-based, soy-based, organic, and others. Enteral nutrition is provided in case of chronic illnesses; while parenteral nutrition is also called intravenous feeding. Geographically, the report is segmented into four regions namely North America, Europe, Asia-Pacific, and LAMEA. In November 2013, Partners in Health, Abbott and Abbott Fund have opened a new nutrition production facility in the Central Plateau in Haiti. Top players in the clinical nutrition market are Abbott nutrition Inc., Ajinomto Co. Inc., Baxter International Inc., B. Braun Medical Inc., Danon Baby and Medical Nutrition BV, Fresenius Kabi AG, Gentiva Health Services Inc., Hospira (Pfizer) Inc., Hero Nutritional Inc., Nestle SA, and Perrigo Company Plc.

KEY MARKET BENEFITS:

  • Comprehensive analysis of factors that drive and restrict the growth of the world clinical nutrition market is provided.
  • Geographically, the world clinical nutrition market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA.
  • SWOT analysis highlights the internal environment of leading companies for effective strategy formulation.
  • The report provides quantitative analysis of the current market and estimations from 2014 to 2020, which would enable the stakeholders to capitalize on prevailing market opportunities.
  • An in-depth analysis of current research and developments within clinical nutrition market is provided with key market dynamic factors that help in understanding the behavior of the market.

KEY MARKET SEGMENTS:

World clinical nutrition market is segmented as below:

  • By Product Type
    • Infant
      • A) Milk-based
      • B) Organic
      • C) Soy-based
      • D) Others
    • Enteral nutrition
      • A) Standard
      • B) Chronic Illness
    • Parenteral nutrition
  • By Geography
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • U.K.
      • France
      • Germany
      • Others
    • Asia-Pacific
      • India
      • China
      • Japan
      • Others
    • LAMEA
      • Latin America
      • Middle East
      • Africa

 

 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

Chapter: 4 CLINICAL NUTRITION MARKET, BY PRODUCT

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. INFANT NUTRITION
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Milk based
4.2.2.1.1. Market size and forecast
4.2.2.2. Soy based
4.2.2.2.1. Market size and forecast
4.2.2.3. Organic formulas
4.2.2.3.1. Market size and forecast
4.2.2.4. Other nutritions
4.2.2.4.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. ENTERAL NUTRITION
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Standard composition
4.3.2.1.1. Market size and forecast
4.3.2.2. Disease specific composition
4.3.2.2.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country
4.4. PARENTERAL NUTRITION
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Amino Acids
4.4.2.1.1. Market size and forecast
4.4.2.2. Fats
4.4.2.2.1. Market size and forecast
4.4.2.3. Carbohydrates
4.4.2.3.1. Market size and forecast
4.4.2.4. Other parenteral nutrition
4.4.2.4.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis, by country

Chapter: 5 CLINICAL NUTRITION MARKET, BY DISEASE TYPE

5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CANCER
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. GASTROINTESTINAL DISEASES
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. NEUROLOGICAL DISEASES
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. RENAL DISEASES
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. RESPIRATORY DISEASES
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
5.7. METABOLIC SYNDROMES
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country
5.8. OTHER DISEASES
5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by country

Chapter: 6 CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION

6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. ORAL
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. ENTERAL
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. PARENTERAL
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

Chapter: 7 CLINICAL NUTRITION MARKET, BY END USER

7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. PEDIATRIC
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. ADULTS
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. GERIATRIC
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country

Chapter: 8 CLINICAL NUTRITION MARKET, BY REGION

8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. Key market trends, growth factors and opportunities
8.2.2. North America clinical nutrition market, by country
8.2.2.1. U.S. clinical nutrition market
8.2.2.1.1. U.S. market, by product
8.2.2.1.2. U.S. market, by disease type
8.2.2.1.3. U.S. market, by route of administration
8.2.2.1.4. U.S. market, by end user
8.2.2.2. Canada clinical nutrition market
8.2.2.2.1. Canada market, by product
8.2.2.2.2. Canada market, by disease type
8.2.2.2.3. Canada market, by route of administration
8.2.2.2.4. Canada market, by end user
8.2.2.3. Mexico clinical nutrition market
8.2.2.3.1. Mexico market, by product
8.2.2.3.2. Mexico market, by disease type
8.2.2.3.3. Mexico market, by route of administration
8.2.2.3.4. Mexico market, by end user
8.2.3. North America clinical nutrition market, by product
8.2.4. North America clinical nutrition market, by disease type
8.2.5. North America clinical nutrition market, by route of administration
8.2.6. North America clinical nutrition market, by end user
8.3. EUROPE
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Europe clinical nutrition market, by country
8.3.2.1. Germany clinical nutrition market
8.3.2.1.1. Germany market, by product
8.3.2.1.2. Germany market, by disease type
8.3.2.1.3. Germany market, by route of administration
8.3.2.1.4. Germany market, by end user
8.3.2.2. France clinical nutrition market
8.3.2.2.1. France market, by product
8.3.2.2.2. France market, by disease type
8.3.2.2.3. France market, by route of administration
8.3.2.2.4. France market, by end user
8.3.2.3. UK clinical nutrition market
8.3.2.3.1. UK market, by product
8.3.2.3.2. UK market, by disease type
8.3.2.3.3. UK market, by route of administration
8.3.2.3.4. UK market, by end user
8.3.2.4. Italy clinical nutrition market
8.3.2.4.1. Italy market, by product
8.3.2.4.2. Italy market, by disease type
8.3.2.4.3. Italy market, by route of administration
8.3.2.4.4. Italy market, by end user
8.3.2.5. Spain clinical nutrition market
8.3.2.5.1. Spain market, by product
8.3.2.5.2. Spain market, by disease type
8.3.2.5.3. Spain market, by route of administration
8.3.2.5.4. Spain market, by end user
8.3.2.6. Rest of Europe clinical nutrition market
8.3.2.6.1. Rest of Europe market, by product
8.3.2.6.2. Rest of Europe market, by disease type
8.3.2.6.3. Rest of Europe market, by route of administration
8.3.2.6.4. Rest of Europe market, by end user
8.3.3. Europe clinical nutrition market, by product
8.3.4. Europe clinical nutrition market, by disease type
8.3.5. Europe clinical nutrition market, by route of administration
8.3.6. Europe clinical nutrition market, by end user
8.4. ASIA-PACIFIC
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Asia-Pacific clinical nutrition market, by country
8.4.2.1. Japan clinical nutrition market
8.4.2.1.1. Japan market, by product
8.4.2.1.2. Japan market, by disease type
8.4.2.1.3. Japan market, by route of administration
8.4.2.1.4. Japan market, by end user
8.4.2.2. China clinical nutrition market
8.4.2.2.1. China market, by product
8.4.2.2.2. China market, by disease type
8.4.2.2.3. China market, by route of administration
8.4.2.2.4. China market, by end user
8.4.2.3. Australia clinical nutrition market
8.4.2.3.1. Australia market, by product
8.4.2.3.2. Australia market, by disease type
8.4.2.3.3. Australia market, by route of administration
8.4.2.3.4. Australia market, by end user
8.4.2.4. India clinical nutrition market
8.4.2.4.1. India market, by product
8.4.2.4.2. India market, by disease type
8.4.2.4.3. India market, by route of administration
8.4.2.4.4. India market, by end user
8.4.2.5. South Korea clinical nutrition market
8.4.2.5.1. South Korea market, by product
8.4.2.5.2. South Korea market, by disease type
8.4.2.5.3. South Korea market, by route of administration
8.4.2.5.4. South Korea market, by end user
8.4.2.6. Rest of Asia-Pacific clinical nutrition market
8.4.2.6.1. Rest of Asia-Pacific market, by product
8.4.2.6.2. Rest of Asia-Pacific market, by disease type
8.4.2.6.3. Rest of Asia-Pacific market, by route of administration
8.4.2.6.4. Rest of Asia-Pacific market, by end user
8.4.3. Asia-Pacific clinical nutrition market, by product
8.4.4. Asia-Pacific clinical nutrition market, by disease type
8.4.5. Asia-Pacific clinical nutrition market, by route of administration
8.4.6. Asia-Pacific clinical nutrition market, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. LAMEA clinical nutrition market, by country
8.5.2.1. Brazil clinical nutrition market
8.5.2.1.1. Brazil market, by product
8.5.2.1.2. Brazil market, by disease type
8.5.2.1.3. Brazil market, by route of administration
8.5.2.1.4. Brazil market, by end user
8.5.2.2. Saudi Arabia clinical nutrition market
8.5.2.2.1. Saudi Arabia market, by product
8.5.2.2.2. Saudi Arabia market, by disease type
8.5.2.2.3. Saudi Arabia market, by route of administration
8.5.2.2.4. Saudi Arabia market, by end user
8.5.2.3. South Africa clinical nutrition market
8.5.2.3.1. South Africa market, by product
8.5.2.3.2. South Africa market, by disease type
8.5.2.3.3. South Africa market, by route of administration
8.5.2.3.4. South Africa market, by end user
8.5.2.4. Rest of LAMEA clinical nutrition market
8.5.2.4.1. Rest of LAMEA market, by product
8.5.2.4.2. Rest of LAMEA market, by disease type
8.5.2.4.3. Rest of LAMEA market, by route of administration
8.5.2.4.4. Rest of LAMEA market, by end user
8.5.3. LAMEA clinical nutrition market, by product
8.5.4. LAMEA clinical nutrition market, by disease type
8.5.5. LAMEA clinical nutrition market, by route of administration
8.5.6. LAMEA clinical nutrition market, by end user

Chapter: 9 COMPANY PROFILES

9.1. BAXTER INTERNATIONAL INC.
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. B. BRAUN MELSUNGEN AG
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. DANONE NUTRICIA
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. MEAD JOHNSON & COMPANY, LLC.
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. NESTLÉ S.A.
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. PERRIGO COMPANY PLC
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. HOSPIRA INC.
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. ABBOTT LABORATORIES
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. FRESENIUS SE & CO. KGAA
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. LONZA LTD
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
World Clinical Nutrition Market- Opportunities and Forecast, 2014 - 2022

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo